Trabectedin and its potential in the treatment of soft tissue sarcoma

Trabectedin and its potential in the treatment of soft tissue sarcoma

Philippe A Cassier1, Armelle Dufresne1, Jean-Yves Blay1,2,3, J&eacute;r&ocirc;me Fayette2,31Unit&eacute; de Jour d&rsquo;Oncologie M&eacute;dicale Multidisciplinaire, H&ocirc;pital Edouard Herriot, Lyon, France; 2D&eacute;partement d&rs...

Full description

Bibliographic Details
Main Authors:	Philippe A Cassier, Armelle Dufresne, Jean-Yves Blay, J&eacute;r&ocirc;me Fayette
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-03-01
Series:	Therapeutics and Clinical Risk Management
Online Access:	http://www.dovepress.com/trabectedin-and-its-potential-in-the-treatment-of-soft-tissue-sarcoma-a1290

Similar Items

Trabectedin in Soft Tissue Sarcomas
by: Bradley J. Petek, et al.
Published: (2015-02-01)

The value of trabectedin in the treatment of soft tissue sarcoma
by: Nakamura T, et al.
Published: (2016-01-01)

Role of trabectedin in the treatment of soft tissue sarcoma
by: Alexandre Christinat, et al.
Published: (2009-05-01)

Trabectedin for advanced soft tissue sarcomas: optimizing use
by: Reid A, et al.
Published: (2014-12-01)

Trabectedin for the treatment of advanced metastatic soft tissue sarcoma
by: EL Simpson, et al.
Published: (2010-05-01)

New developments in treatment of ovarian carcinoma: focus on trabectedin
by: Philippe A Cassier, et al.
Published: (2010-10-01)

Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas
by: Audrey Laroche, et al.
Published: (2017-04-01)

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
by: Recine F, et al.
Published: (2017-02-01)

Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma
by: Maud Maillard, et al.
Published: (2020-12-01)

Pazopanib for the treatment of soft-tissue sarcoma
by: Heudel P, et al.
Published: (2012-10-01)

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin
by: Desar IME, et al.
Published: (2016-08-01)

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma
by: De Sanctis R, et al.
Published: (2015-10-01)

Trabectedin for Metastatic Soft Tissue Sarcoma: A Retrospective Single Center Analysis
by: Anthony D. Ho, et al.
Published: (2010-10-01)

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma [Corrigendum]
by: De Sanctis R, et al.
Published: (2016-01-01)

The Use of Positron Emission Tomography in Soft Tissue Sarcoma Patients under Therapy with Trabectedin
by: Gerlinde Egerer, et al.
Published: (2009-07-01)

Trabectedin Drug Holiday and Rechallenge in Soft Tissue Sarcomas: Report of 4 Cases and Literature Review
by: Francesco Pierantoni, et al.
Published: (2019-07-01)

Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients
by: Michiel C. Verboom, et al.
Published: (2019-01-01)

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group
by: Emanuela Palmerini, et al.
Published: (2021-03-01)

Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center
by: Nadia Hindi, et al.
Published: (2020-12-01)

Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin
by: Gianmaria Miolo, et al.
Published: (2020-07-01)

Trabectedin: Safety and Efficacy in the Treatment of Advanced Sarcoma
by: Csaba Gajdos, et al.
Published: (2011-01-01)

Optimizing Trabectedin Therapy for the Treatment of Ewing Sarcoma
by: Harlow, Matthew
Published: (2017)

Combination of Trabectedin and Gemcitabine for Advanced Soft Tissue Sarcomas: Results of a Phase I Dose Escalating Trial of the German Interdisciplinary Sarcoma Group (GISG)
by: Bernd Kasper, et al.
Published: (2015-01-01)

Very long‐term survivors among patients with metastatic soft tissue sarcoma
by: Mélodie Carbonnaux, et al.
Published: (2019-04-01)

Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin
by: Alexandre de Nonneville, et al.
Published: (2019-03-01)

Cost Effectiveness of First-Line Treatment with Doxorubicin/Ifosfamide Compared to Trabectedin Monotherapy in the Management of Advanced Soft Tissue Sarcoma in Italy, Spain, and Sweden
by: Julian F. Guest, et al.
Published: (2013-01-01)

Time lapse analysis of tumor response in patients with soft tissue sarcoma treated with trabectedin: A pooled analysis of two phase II clinical trials
by: Makoto Endo, et al.
Published: (2020-06-01)

Trabectedin in Advanced Sarcomas—Experience at a Tertiary Care Center and Review of Literature
by: Saurav Verma, et al.
Published: (2021-04-01)

A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study
by: Javier Martínez-Trufero, et al.
Published: (2021-02-01)

Neoadjuvant Trabectedin plus Radiotherapy in High-Grade Sarcoma of the Leg: A Case Report
by: António José Loureiro da Silva, et al.
Published: (2018-07-01)

Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models
by: Lucia Martinez-Cruzado, et al.
Published: (2017-06-01)

PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas
by: François Bertucci, et al.
Published: (2017-03-01)

PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target
by: François Bertucci, et al.
Published: (2019-07-01)

Quality of life and added value of a tailored palliative care intervention in patients with soft tissue sarcoma undergoing treatment with trabectedin: a multicentre, cluster-randomised trial within the German Interdisciplinary Sarcoma Group (GISG)
by: Bernd Kasper, et al.
Published: (2020-08-01)

Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort).
by: Olfa Derbel, et al.
Published: (2017-01-01)

Erratum: Hindi, N., et al. Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center. <i>Cancers</i> 2020, <i>12</i>, 3740
by: Nadia Hindi, et al.
Published: (2021-03-01)

Recurrent DMD Deletions Highlight Specific Role of Dp71 Isoform in Soft-Tissue Sarcomas
by: Olivier Mauduit, et al.
Published: (2019-07-01)

Trabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable Toxicity
by: J. Herzog, et al.
Published: (2016-01-01)

Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer
by: Robin L. Jones, et al.
Published: (2021-06-01)

Soft tissue sarcomas of the kidney
by: Olivia Köhle, et al.
Published: (2015-03-01)